Glecaprevir
ATC J05AP57 · 10 markets · 22 records
AU 5 records · 3 strengths
- 100 mgtabletMaviret 100mg/40mg tabletsMAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack、MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle
- 50 mgpowderMAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 4 records · 2 strengths
- 100 mgtabletMaviret 100mg/40mg tabletsManufacturer: AbbVie Ltd
- 50 mgpowderMaviret 50mg/20mg granules sachetsManufacturer: AbbVie Ltd
US 2 records · 2 strengths
CA 2 records · 2 strengths
- 100 mgtabletMaviret 100mg/40mg tablets
- 50 mgpowderMaviret 100mg/40mg tablets
ES 2 records · 2 strengths
- 40 mgtabletMaviret 100mg/40mg tablets
- 50 mgliquidMAVIRET GRANULOS
FR 2 records · 2 strengths
- 100 mgtabletMAVIRET 100 mg/40 mg, comprimé pelliculé
- 50 mgpowderMAVIRET 50 mg/20 mg, granulés enrobés en sachet
SG 1 records · 1 strengths
- 100 mgtabletMaviret 100mg/40mg tablets
TW 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|
| 100 mg tablet | Mavyret | Manufacturer: AbbVie Ltd ×2 Maviret 100mg/40mg tablets | Maviret 100mg/40mg tablets | Maviret 100mg/40mg tablets MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle | Maviret 100mg/40mg tablets | MAVIRET 100 mg/40 mg, comprimé pelliculé | ||||
| 50 mg powder | Manufacturer: AbbVie Ltd ×2 Maviret 50mg/20mg granules sachets | Maviret 100mg/40mg tablets | MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet | MAVIRET 50 mg/20 mg, granulés enrobés en sachet | ||||||
| 40 mg tablet | Maviret 100mg/40mg tablets | |||||||||
| 50 mg liquid | MAVIRET GRANULOS | |||||||||
| 50 mg pellet | Mavyret | |||||||||
unknown | Maviret 100mg/40mg tablets | Maviret 100mg/40mg tablets | Maviret 100mg/40mg tablets | |||||||
tablet | Maviret 100mg/40mg tablets 艾百樂膜衣錠100毫克/40毫克 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in ES · TW and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en ES · TW que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 ES · TW 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 ES · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.